Heart rehab goes hybrid: can a mix of home and clinic sessions boost adherence?

NCT ID NCT07734831

Not yet recruiting Disease control Sponsor: University of the State of Santa Catarina Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether a hybrid cardiac telerehabilitation program — combining in-person sessions, live video workouts, and remote monitoring — can improve adherence to exercise rehab in people with coronary artery disease or stable heart failure. Participants are randomly assigned to the hybrid program, traditional center-based rehab, or usual care. The study aims to see if a low-tech, flexible model can overcome common barriers to attending rehab.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a hybrid cardiac telerehabilitation program combining in-person, videoconference, and remote exercise sessions
What this could lead to: If effective, this hybrid model could expand access to cardiac rehabilitation for patients facing logistical or geographic barriers.
What could go wrong: This is a single-center trial with 219 participants, so results may not apply broadly. Adherence and safety in a real-world setting remain uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROMES (ACS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome Angina Pectoris congestive heart failure coronary artery disorder heart failure myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROMES (ACS) CHRONIC HEART FAILURE CORONARY ARTERY DISEASE (CAD) (E.G., ANGINA, MYOCARDIAL INFARCTION, AND ATHEROSCLEROTIC HEART DISEASE (ASHD))

Contacts and locations

Locations

Centro de Ciências da Saúde e do Esporte (CEFID/UDESC)

Florianópolis, Santa Catarina, 88080-350, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.